Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

(2017) Pietro Lampertico et al.   JOURNAL OF HEPATOLOGY

Overview of hepatitis B viral replication and genetic variability

(2016) Shuping Tong et al.   JOURNAL OF HEPATOLOGY

Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy

(2016) A. Velay et al.   JOURNAL OF VIRAL HEPATITIS

Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe

(2015) R. Ozaras et al.   CLINICAL MICROBIOLOGY AND INFECTION

Molecular mechanisms underlying HBsAg negativity in occult HBV infection

(2015) R. A. A. Pondé   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression

(2015) Romina Salpini et al.   HEPATOLOGY

Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: Sequence analysis and therapeutic strategy

(2015) Monica Luongo et al.   JOURNAL OF CLINICAL VIROLOGY

Baseline interpatient hepatitis B viral diversity differentiates HBsAg outcomes in patients treated with tenofovir disoproxil fumarate

(2015) Prista Charuworn et al.   JOURNAL OF HEPATOLOGY

Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy–Experienced Patients in Europe (CAPRE)

(2015) Lucas Etienne Hermans et al.   JOURNAL OF INFECTIOUS DISEASES

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

(2015) Aparna Schweitzer et al.   LANCET

Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications

(2014) Teresa Pollicino et al.   JOURNAL OF HEPATOLOGY

Clinical implications of hepatitis B virus mutations: Recent advances

(2014) Ivana Lazarevic   WORLD JOURNAL OF GASTROENTEROLOGY

Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies

(2013) Victoria Arama et al.   ANTIVIRAL THERAPY

HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient

(2013) Nicola Coppola et al.   JOURNAL OF CLINICAL VIROLOGY

Increased Seroprevalence of HBV DNA With Mutations in the S Gene Among Individuals Greater Than 18 Years Old After Complete Vaccination

(2012) Ming–Wei Lai et al.   GASTROENTEROLOGY

Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion

(2012) Yan Cheng et al.   GUT

Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors

(2012) Cheng-Hao Huang et al.   JOURNAL OF HEPATOLOGY

High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG

(2012) Sajad Shahmoradi et al.   JOURNAL OF HEPATOLOGY

Probable Corticosteroid-Induced Reactivation of Latent Hepatitis B Virus Infection in an HIV-Positive Patient Involving Immune Escape

(2012) Nora Martel et al.   JOURNAL OF INFECTIOUS DISEASES

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection

(2011) Valentina Svicher et al.   ANTIVIRAL RESEARCH

Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseases

(2011) Seoung-Ae Lee et al.   JOURNAL OF HEPATOLOGY

Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia

(2010) Valentina Svicher et al.   DIGESTIVE AND LIVER DISEASE

Differential Impact of Immune Escape Mutations G145R and P120T on the Replication of Lamivudine-Resistant Hepatitis B Virus e Antigen-Positive and -Negative Strains

(2009) S. Amini-Bavil-Olyaee et al.   JOURNAL OF VIROLOGY

The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

(2008) Nadia Warner et al.   HEPATOLOGY

The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes

(2008) Valentina Svicher et al.   JOURNAL OF HEPATOLOGY